News
Hosted on MSN9mon
FDA rejects MDMA for treating PTSDCalifornia Congressman Lou Correa says the psychedelic drug, known as ecstasy, shows real promise in easing veterans’ PTSD ... Sabet says MDMA may be helpful for some, but the broader ...
RELATED STORY | FDA panel rejects the use of psychedelic drug MDMA to treat patients with PTSD Lykos said the issues FDA raised in what's called a complete response letter echoed the concerns ...
A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to ...
The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...
Multidisciplinary Association for Psychedelic Studies (MAPS), the FDA has agreed study designs for two phase 3 studies assessing MDMA-assisted psychotherapy for patients with severe PTSD.
the U.S. Food and Drug Administration (FDA) made the decision not to approve MDMA-assisted therapy for post-traumatic stress disorder. This decision comes just months after advisors to the agency ...
The same might soon happen with MDMA (a.k.a., ecstasy), the party drug that’s showing great promise in treating PTSD and other anxiety-related disorders. DON’T MISS: Answers to burning ...
The Multidisciplinary Association for Psychedelic Studies, or MAPS for short, is conducting a series of tests to find out if the illegal drug MDMA, also known as Ecstasy, could be used to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results